William Hearl - 07 Jun 2022 Form 4 Insider Report for MARIZYME INC (MRZM)

Reporting relationship: Director
Issuer ticker: MRZM
Reported as of: 07 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2022, 18:28:17 UTC
Prior SEC filing: 07 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ William Hearl

Key filing fact

William Hearl filed Form 4 for MARIZYME INC (MRZM) on 09 Jun 2022.

Key facts

This page summarizes William Hearl's Form 4 filing for MARIZYME INC (MRZM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2022, 18:28.

Change

Previous filing in this sequence was filed on 07 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRZM transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +40,000
Change %
Price: $0.000000
Shares after: 40,000
Date: 07 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,000
Exercise price: $2.20
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of an option to purchase 40,000 shares of common stock granted to the reporting person on June 7, 2022. The option vests over one year on a monthly basis in equal installments starting July 1, 2022.